Considering the prevalence of mutations in lung cancer and subsequent heterogeneous outcomes [2], we hypothesize that there are additional prognosis markers for patients with KRAS mutations, which may be possibly based on unseen traits of the gene. Here, KRAS is linked to lung carcinoma.